drugset / Trial / NCT03129113
Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV
Phase 2/3
Completed
90 enrolled
University College, London
Medical Research Council · collabRoyal Free Hospital NHS Foundation Trust · collabViiV Healthcare · collab
RandomizedFactorialSingle-blindTreatment
Summary
This is a multicentre, phase IV, randomised, open-label, trial exploring adjunctive maraviroc and/or metformin for liver steatosis over 48 weeks. Sponsored by University College London Coordinated by MRC Clinical Trials Unit at UCL
Timeline
- Start
- 2017-03-01
- Primary completion
- 2020-11-05
- Completion
- 2020-11-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maraviroc | Other / unclassified | — | Oral |
| Subject | Metformin | Small molecule | 500 mg | Oral |